Application of Differential Scanning Calorimetry and Fourier Transform Infrared Spectroscopy to the Study of Metoprolol-Excipient and Lisinopril-Excipient Compatibility
More details
Hide details
Department of Bioengineering, Faculty of Engineering and Architecture, Mehmet Akif Ersoy University, Burdur, TURKEY
Research and Practice Center, Mehmet Akif Ersoy University, Burdur, TURKEY
Online publish date: 2018-07-01
Publish date: 2018-07-01
Eurasian J Anal Chem 2018;13(5):em39
Studies of pharmaceutical drug/active pharmaceutical ingredient (API) compatibility represent an important phase in the design or development of new formulation stage and drug delivery systems. Excipients in the formulations are influenced by the chemical nature, stability, manufacturability, drug bioavailability or delivery of the drug to the patient. Differential scanning calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FTIR) were used as an analytical screening technique for defining the conformity, quality, ability, compatibility of metoprolol and lisinopril with some recently employed pharmaceutical excipients.
1. Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. Journal of Excipients and Food Chemicals. 2010;1(3):3-26.
2. Pandian P, Kannan K, Manikandan M, Manavalan R. Formulation and evaluation of oseltamivir phosphate capsules. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4:342-347.
3. Aulton ME. Pharmaceutics: the science of dosage form design. Churchill Livingstone. 2002. Retrieved from
4. Ford JL, Timmins P. In: Rubinstein MH, editor. Pharmaceutical thermal analysis: Techniques and applications. Ellis Horwood Ltd., 1989.
5. Wang Z, Horikawa T, Hirayama F, Uekama K. Design and in vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose. Journal of Pharmacy and Pharmacology. 1993;45:942–946.
6. Sims JL, Carreira JA, Carrier DJ, Crabtree SR, Easton L, Hancock SA, Simcox CE. A new approach to accelerated drug-excipient compatibility testing. Pharmaceutical Development and Technology. 2003;8:119–126.
7. Clas SD, Dalton CR, Hancock BC. Differential scanning calorimetry: Applications in drug development. Pharmaceutical Development and Technology. 1999;2:311–320.
8. Giron D. Contribution of thermal methods and related techniques to the rational development of pharmaceuticals: Part 2. Pharmaceutical Science & Technology. 1998;1:262–268.
9. Singh AV. A DSC study of some biomaterials relevant to pharmaceutical industry. The Journal of Thermal Analysis and Calorimetry. 2013;112:791–793.
10. Vueba ML, Veiga F, Sousa JJ, Pina ME. Compatibility studies between ibuprofen or ketoprofen with cellulose ether polymer mixtures using thermal analysis. Drug Development and Industrial Pharmacy. 2005;31:943–949.
11. Mura P, Faucci MT, Manderioli A, Bramanti G, Ceccarelli L. Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. Journal of Pharmaceutical and Biomedical Analysis. 1998;18:151–163.
12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A. 2007 ESH-ESC Practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. Journal of Hypertension. 2007;25:1751-1762.
13. Bras NF, Fernandes PA, Ramos MJ. QM/MM study and MD simulations on the hypertension regulator angiotensin-converting enzyme. ACS Catalysis. 2014;4:2587–2597.
14. Beevers DG, Blackwood RA, Garnham S, Watson M, Mehrzad AA, Admani K, Angell-James JE, Feely M, Kumar S, Husaini MH, Mannering D, Connett C, Long C. Comparison of lisinopril versus atenolol for mild to moderate essential hypertension. American Journal of Cardiology. 1991;67:59–62.
15. Yilmaz B, Arslan S. Development and validation of GC–MS method for determination of metoprolol in human urine. Journal of Chromatographic Science. 2010;48:613-617.
16. Bandari S, Gangishetty S, Eedara BB, Jukanti R, Veerareddy PR. Proliposomes of lisinopril dihydrate for transdermal delivery: Formulation aspects and evaluation. Korean Journal of Chemical Engineering. 2013;30:1659-1666.
17. Fujii K, Uekusa H, Itoda N, Yonemochi E, Terada K. Mechanism of dehydration–hydration processes of lisinopril dihydrate investigated by ab initio powder X-ray diffraction analysis. Crystal Growth & Design. 2012;12:6165–6172.
18. Shinde V, Trivedi A, Upadhayay PR, Gupta NL, Kanase DG, Chikate R. Identification of a new impurity in lisinopril. Journal of Pharmaceutical and Biomedical Analysis. 2007;43:381–386.
19. Chaudhari SP, Pradeep SP. Pharmaceutical Excipients: A review. International Journal of Advances In Pharmacy, Biology and Chemistry. 2012;1:21-34. Retrieved from
20. Macedo RO, Gomes do Nascimento T, Veras JWE. Compatibility and stability studies of propranolol hydrochloride binary mixtures and tablets for TG and DSC-photovisual. Journal of Thermal Analysis and Calorimetry. 2002;67:483–489.
21. Marini A, Berbenni V, Moioli S, Bruni G, Cofrancesco P, Margheritis C, Villa M. Drug-excipient compatibility studies by physico-chemical techniques: The case of Indomethacin. Journal of Thermal Analysis and Calorimetry. 2003;73:529–545.
22. Tit B, Fulias A, Bandurb G, Marianc E, Tit D. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms. Journal of Pharmaceutical and Biomedical Analysis. 2011;56:221–227.
23. Gao R, Sun BW, Lin J, Gao XL. Compatibility of medroxyprogesterone acetate and pharmaceutical excipients through thermal and spectroscopy techniques. Journal of Thermal Analysis and Calorimetry. 2014;117:731–739.
24. Joshi BV, Patil VB, Pokharkar VB. Compatibility studies between carbamazepine and tablet excipients using thermal and nonthermal methods. Drug Development and Industrial Pharmacy. 2002;28:687–694.
25. Monajjemzadeh F, Hassanzadeh D, Valizadeh H, Siahi-Shadbad MR, Mojarrad JS, Robertson TA, Roberts MS. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets. The European Journal of Pharmaceutics and Biopharmaceutic. 2009;73:404–413.
26. Swathi R, Sunitha Reddy M. UV-Visible spectrometric method and validation, compatibility studies of nevirapine cubosome formulation. World Journal of Pharmacy and Pharmaceutical Sciences. 2017;6(01):111-1121.
27. Bozdağ-Pehlivan S, Subaşı B, Vural I, Ünlü N, Capan Y. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets. Acta Poloniae Pharmaceutica - Drug Research. 2011;68(3):423-33. Retrieved from
28. Wakasawa T, Sano K, Hirakura Y, Toyooka T, Kitamura S. Solid-state compatibility studies using a high-throughput and automated forced degradation system. International Journal of Pharmaceutics. 2008;355:164–173.
29. Pani NR, Nath LK, Acharya S. Compatibility studies of nateglinide with excipients in immediate release tablets. Acta Pharmaceutica. 2011;61:237–247.
30. Abou El Ala AES, El Khatib MM. Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels. The Saudi Pharmaceutical Journal. 2014;22(6):555-563.
31. Mura P, Manderioli A, Bramanti G, Furlanetto S, Pinzauti S. Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients. International Journal of Pharmaceutics. 1995;119:71-79.
32. Manikandan M, Kannan K, Manavalan R. Compatibility studies of camptothecin with various pharmaceutical excipients used in the development of nanoparticle formulation. International Journal of Pharmacy and Pharmaceutical Science. 2013;5(4):315-321.
33. Dahiya S, Gupta ON. Formulation and in vitro evaluation of metoprolol tartarate microspheres. Bulletin of Pharmaceutical Research. 2011;1(1):31-39. Retrieved from
34. Khan MS, Vishakante GD, Bathool A. Preparation and evaluation of sodium alginate porous dosage form as carriers for low dosed active pharmaceutical ingredients. Turkish Journal of Pharmaceutical Sciences. 2012;9(2):183-198. Retrieved from
35. Dadarwal SC, Madan SS, Agrawal S. Formulation and evaluation of delayed-onset extended-release tablets of metoprolol tartrate using hydrophilic-swellable polymers. Acta Pharmaceutica. 2012;62:105-114.
36. Sbârcea L, Udrescu L, Ledeţi I, Szabadai Z, Fuliaş A, Sbârcea C. β-Cyclodextrin inclusion complexes of lisinopril and zofenopril physicochemical characterization and compatibility study of lisinopril-b-cyclodextrin with lactose. Journal of Thermal Analysis and Calorimetry. 2016;123:2377–2390.
37. Wang SL, Lin SY, Chen TF. Thermal-dependent dehydration process and intramolecular cyclization of lisinopril dihydrate in the solid state. Chemical and Pharmaceutical Bulletin. 2000;48(12):1890-1893.
38. Panigrahi R, Chowdary KA, Mishra G, Bhowmik M, Behera S. Formulation of fast dissolving tablets of Lisinopril using combination of synthetic superdisintegrants. Asian Journal of Pharmacy and Technology. 2012;2:94-98. Retrieved from